4-Substituted cyclohexyl sulfones as potent, orally active γ-secretase inhibitors

[1]  I. Churcher,et al.  γ-Secretase as a Therapeutic Target for the Treatment of Alzheimers Disease , 2005 .

[2]  A. Weng,et al.  Notch signaling in T-cell acute lymphoblastic leukemia , 2005 .

[3]  Hans Clevers,et al.  Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells , 2005, Nature.

[4]  Timothy Harrison,et al.  Aryl sulfones : A new class of γ-secretase inhibitors , 2005 .

[5]  A. Nadin,et al.  Quantitative Measurement of Changes in Amyloid-β(40) in the Rat Brain and Cerebrospinal Fluid following Treatment with the γ-Secretase Inhibitor LY-411575 [N2-[(2S)-2-(3,5-Difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-l-alaninamide] , 2005, Journal of Pharmacology and Experimental Therapeutics.

[6]  G. Schettini,et al.  The amyloid precursor protein and its network of interacting proteins: physiological and pathological implications , 2005, Brain Research Reviews.

[7]  T. Bird.  Genetic factors in Alzheimer's disease. , 2005, The New England journal of medicine.

[8]  R. Tanzi,et al.  Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.

[9]  S. Pollack,et al.  Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease. , 2005, Current opinion in investigational drugs.

[10]  Marcela Colombres,et al.  Structure and function of amyloid in Alzheimer's disease , 2004, Progress in Neurobiology.

[11]  A. Nadin,et al.  Selected Non-steroidal Anti-inflammatory Drugs and Their Derivatives Target γ-Secretase at a Novel Site , 2004, Journal of Biological Chemistry.

[12]  T. Kadesch,et al.  Notch signaling: the demise of elegant simplicity. , 2004, Current opinion in genetics & development.

[13]  Dan Yang,et al.  Investigation on the regioselectivities of intramolecular oxidation of unactivated C-H bonds by dioxiranes generated in situ. , 2003, The Journal of organic chemistry.

[14]  A. Nadin,et al.  Catalytic Site-Directed γ-Secretase Complex Inhibitors Do Not Discriminate Pharmacologically between Notch S3 and β-APP Cleavages , 2003 .

[15]  P. Winocour,et al.  Novel bicyclic lactam inhibitors of thrombin: highly potent and selective inhibitors. , 2002, Bioorganic & medicinal chemistry letters.

[16]  M. Shearman,et al.  Quantitation of amyloid-β peptides in biological milieu using a novel homogeneous time-resolved fluorescence (HTRF) assay , 2000, Journal of Neuroscience Methods.

[17]  B. Greenberg,et al.  Turnover of Amyloid β-Protein in Mouse Brain and Acute Reduction of Its Level by Phorbol Ester , 1998, The Journal of Neuroscience.

[18]  D. Price,et al.  Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice , 1993, Nature Genetics.

[19]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.